Clinical Trials in New York

Showing 7041-7060 of 17,259 trials

A Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists.

NCT03389750

Significant public health concerns have arisen from the intravenous misuse of oxymorphone, a potent mu-opioid pain medication. However, little is known about its abuse potential relative to other mu-opioid analgesics. The present study is designed to examine the abuse liability of intravenous oxymorphone compared to other mu opioid agonists (oxycodone, and hydromorphone) among physically dependent opioid abusers.

Opioid Use Disorder

New York State Psychiatric Institute16 participantsStarted Mar 2018

Lexington, Kentucky, United States • New York, New York, United States

COMPLETEDNA< 1 mile

Clinical Evaluation of Fractional Radiofrequency for the Treatment and Reduction of Facial Wrinkles

NCT03831477

Prospective, single centre, evaluator-blind study of the safety and performance of fractional radiofrequency (RF) for the treatment and reduction of facial wrinkles.

RhytidesWrinkle

Venus Concept15 participantsStarted Dec 2018

New York, New York, United States

COMPLETED< 1 mile

Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C"

NCT04144738

The primary objective of this study is to assess the sensitivity for colorectal cancer (CRC) and specificity of the mt-sDNA 2.0 test.

Colorectal Cancer

Exact Sciences Corporation26,758 participantsStarted Nov 2019

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +192 more locations

A Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists.

Clinical Evaluation of Fractional Radiofrequency for the Treatment and Reduction of Facial Wrinkles

Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C"

Find Trials by Condition in New York

Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia

Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic Dermatitis

Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia

KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis

Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-naive Participants

The Effect of Pretreatment for Propionibacterium Acnes on Surgical Site Burden in Shoulder Arthroplasty

Lidocaine Intravenous in the Emergency Department For Sickle Cell Crisis

Dociparstat Sodium (CX-01) Combined With Standard Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia

EyeBOX Concussion Study and Registry

Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis

Intermittent Hypoxia and Caffeine in Infants Born Preterm

Investigation to Minimize Prolapse Recurrence of the Vagina Using Estrogen

Low-Dose Atropine for Treatment of Myopia

A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous EDP1815 Trials

Assessment of the Safety and Efficacy Study of RGN-259 Ophthalmic Solutions for Neurotrophic Keratopathy : SEER-1

Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 2

Study of Emerfetamab (AMG 673) in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML)